Document Detail

The medicalisation of 'tall' girls: A discourse analysis of medical literature on the use of synthetic oestrogen to reduce female height.
MedLine Citation:
PMID:  20678835     Owner:  NLM     Status:  MEDLINE    
Endocrine research in the 1930s increased and extended the use of sex hormones as medical therapies in an unprecedented way, especially for female ailments. In the 1950s the therapeutic use of sex hormones extended to the treatment of 'tall' girls. Ambiguity in the definition of the 'tall' girl, the arbitrary nature of the treatment decision, and diversity in the therapeutic regimes highlight the problematic nature of this medical practice. Using linguistic repertoires to study the political and ideological implications found in the patterned use of language, this paper reports on a discourse analysis of the medical literature on treatment of tall girls between the 1950s and 1990s, when this treatment was at its peak. Three linguistic repertoires emerged: the institutional authority of medicine to determine the 'abnormality' of tall stature in females; the clinical knowledge and experience in the diagnosis of medical risk associated with tall stature in women; and using hormones as cosmetic therapy to (re)produce femininity in tall girls. All three related to the maintenance of the cultural representations and social expectations of femininity. With no evidence of psychological harm associated with tall stature in women, and no long-term studies of either effectiveness or benefit, over five decades clinicians persuaded themselves and their patients that tall stature required therapeutic intervention. The treatment of tall girls with high dose oestrogen must be viewed as the medicalisation of a normal physical attribute adversely related to the social construction of gender.
Jo-Anne Rayner; Priscilla Pyett; Jill Astbury
Related Documents :
16966135 - Minimally invasive diagnostics and treatment using micro/nano machining.
1971975 - Pharmacologic approaches to the treatment of cocaine dependence.
2435045 - 5-fluorouracil (5-fu) in the treatment of prostatic hyperplasia.
17235155 - Parenteral treatment of clinical mastitis with tylosin base or penethamate hydriodide i...
21440275 - Formal training in medical journalism: why, who, when, how?
8979525 - Trends of smoking among medical students.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2010-07-13
Journal Detail:
Title:  Social science & medicine (1982)     Volume:  71     ISSN:  1873-5347     ISO Abbreviation:  Soc Sci Med     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-16     Completed Date:  2010-09-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8303205     Medline TA:  Soc Sci Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  1076-83     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Ltd. All rights reserved.
Mother and Child Health Research, La Trobe University, 324-328 Little Lonsdale St, Melbourne, Victoria 3000, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Attitude of Health Personnel
Body Height / drug effects*
Estradiol Congeners / therapeutic use*
Growth Disorders / drug therapy*
Physician's Practice Patterns*
Social Values
Reg. No./Substance:
0/Estradiol Congeners

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Psychotherapeutic interventions for depressed, low-income women: a review of the literature.
Next Document:  Evidence based public health: A review of the experience of the National Institute of Health and Cli...